Skip to main content
RAPS Euro Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Rebecca Lumsden, PhD

Head of Regulatory Science & Policy EU/AMEE
Sanofi, United Kingdom

Rebecca recently joined Sanofi to lead their regulatory science and policy efforts in Europe, Africa and the Middle East and coordinate specific global projects with a goal of fostering new approaches for early access of medicines for the benefit of patients. Focus areas include expedited regulatory pathways, regulatory convergence, digital transformation and includes adapting regulatory frameworks to new science and in support of innovative technologies. She is actively involved within EFPIA and is a member of a CIRS topic group.
Before joining Sanofi, she was a Director in the Global Regulatory Policy & Intelligence team at Pfizer and also held the role of Co-Chair of the FIFARMA’s Regulatory and Biologics Working Group (2020-2022). Her career has included 8 years at the UK Trade Association (ABPI) working on numerous policy issues relevant to the biopharmaceutical industry including science and innovation policy. She was a post-doctoral scientist prior to her career in policy, with a PhD from Fitzwilliam College, University of Cambridge (UK) in cell signalling.

Disclosure information not submitted.

Presentation(s):